Northwest Bancshares’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.35M | Sell |
2,551
-65
| -2% | -$65.9K | 0.47% | 54 |
|
|
2025
Q4 | $2.81M | Sell |
2,616
-1,060
| -29% | -$1.01M | 0.54% | 52 |
|
|
2025
Q3 | $2.8M | Hold |
3,676
| – | – | 0.47% | 51 |
|
|
2025
Q2 | $2.87M | Sell |
3,676
-111
| -3% | -$86.3K | 0.5% | 49 |
|
|
2025
Q1 | $3.13M | Sell |
3,787
-75
| -2% | -$62.4K | 0.57% | 46 |
|
|
2024
Q4 | $2.98M | Sell |
3,862
-1,024
| -21% | -$848K | 0.55% | 46 |
|
|
2024
Q3 | $4.33M | Sell |
4,886
-227
| -4% | -$204K | 0.74% | 39 |
|
|
2024
Q2 | $4.63M | Sell |
5,113
-731
| -13% | -$585K | 0.79% | 40 |
|
|
2024
Q1 | $4.55M | Buy |
5,844
+268
| +5% | +$191K | 0.72% | 45 |
|
|
2023
Q4 | $3.25M | Sell |
5,576
-505
| -8% | -$295K | 0.59% | 45 |
|
|
2023
Q3 | $3.27M | Buy |
6,081
+268
| +5% | +$138K | 0.63% | 47 |
|
|
2023
Q2 | $2.73M | Sell |
5,813
-119
| -2% | -$49.9K | 0.49% | 49 |
|
|
2023
Q1 | $2.04M | Sell |
5,932
-368
| -6% | -$124K | 0.39% | 58 |
|
|
2022
Q4 | $2.3M | Sell |
6,300
-15
| -0.2% | -$5.32K | 0.46% | 54 |
|
|
2022
Q3 | $2.04M | Sell |
6,315
-2,056
| -25% | -$651K | 0.48% | 54 |
|
|
2022
Q2 | $2.71M | Sell |
8,371
-620
| -7% | -$186K | 0.61% | 51 |
|
|
2022
Q1 | $2.58M | Sell |
8,991
-290
| -3% | -$74.6K | 0.5% | 56 |
|
|
2021
Q4 | $2.56M | Hold |
9,281
| – | – | 0.5% | 55 |
|
|
2021
Q3 | $2.15M | Sell |
9,281
-100
| -1% | -$24.7K | 0.49% | 58 |
|
|
2021
Q2 | $2.15M | Sell |
9,381
-150
| -2% | -$30.1K | 0.49% | 58 |
|
|
2021
Q1 | $1.78M | Sell |
9,531
-216
| -2% | -$42.3K | 0.42% | 65 |
|
|
2020
Q4 | $1.65M | Sell |
9,747
-92
| -0.9% | -$13.7K | 0.42% | 69 |
|
|
2020
Q3 | $1.46M | Sell |
9,839
-425
| -4% | -$65.8K | 0.38% | 80 |
|
|
2020
Q2 | $1.69M | Buy |
10,264
+1,175
| +13% | +$180K | 0.46% | 73 |
|
|
2020
Q1 | $1.26M | Sell |
9,089
-905
| -9% | -$124K | 0.63% | 53 |
|
|
2019
Q4 | $1.31M | Sell |
9,994
-558
| -5% | -$64.7K | 0.51% | 57 |
|
|
2019
Q3 | $1.18M | Sell |
10,552
-67
| -0.6% | -$7.46K | 0.49% | 60 |
|
|
2019
Q2 | $1.18M | Buy |
10,619
+29
| +0.3% | +$3.42K | 0.5% | 60 |
|
|
2019
Q1 | $1.37M | Hold |
10,590
| – | – | 0.59% | 58 |
|
|
2018
Q4 | $1.23M | Sell |
10,590
-291
| -3% | -$32.5K | 0.59% | 57 |
|
|
2018
Q3 | $1.17M | Buy |
10,881
+125
| +1% | +$12.5K | 0.52% | 65 |
|
|
2018
Q2 | $918K | Sell |
10,756
-300
| -3% | -$24.6K | 0.39% | 72 |
|
|
2018
Q1 | $855K | Hold |
11,056
| – | – | 0.35% | 72 |
|
|
2017
Q4 | $934K | Buy |
+11,056
| New | +$941K | 0.38% | 70 |
|
Other funds holding LLY
VCM
VPM
Northwest Bancshares's LLY Position: Q1 2026 in Review
Northwest Bancshares reduced its Eli Lilly (LLY) stake by 2.5% in Q1 2026, selling an estimated $65.9K and leaving 2,551 shares worth $2.35M. The position accounts for 0.47% of the portfolio, ranked #54.
Northwest Bancshares first reported a position in LLY in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.63M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Northwest Bancshares held 2,551 shares of Eli Lilly worth $2.35M as of Q1 2026.
- Northwest Bancshares sold 65 Eli Lilly shares in Q1 2026, an estimated $65.9K.
- Eli Lilly made up 0.47% of Northwest Bancshares's portfolio in Q1 2026, its #54 holding.
- Northwest Bancshares first reported a position in Eli Lilly in Q4 2017 and has held it in 34 quarters since.
- Northwest Bancshares's Eli Lilly position peaked at $4.63M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Northwest Bancshares's 13F filing for Q1 2026, filed 12 May 2026.